{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T14:13:22Z","timestamp":1789049602267,"version":"build-2803163510"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Abdom Radiol"],"DOI":"10.1007\/s00261-026-05780-y","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T13:38:45Z","timestamp":1789047525000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prostate MRI reporting and its impact on clinical decision-making: the urologists\u2019 perspective"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0651-1579","authenticated-orcid":false,"given":"Mert Emre","family":"Erden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9381-4083","authenticated-orcid":false,"given":"Seyfettin An\u0131l","family":"Tantekin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0269-9309","authenticated-orcid":false,"given":"Ahmad","family":"Gharehmohammadlou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5801-6898","authenticated-orcid":false,"given":"\u00d6ner","family":"\u015eanl\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,10]]},"reference":[{"key":"5780_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL et al (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 71:209\u2013249","journal-title":"CA Cancer J Clin"},{"key":"5780_CR2","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.euo.2020.06.007","volume":"3","author":"F Giganti","year":"2020","unstructured":"Giganti F, Allen C, Emberton M, Moore CM, Kasivisvanathan V, group Ps (2020) Prostate Imaging Quality (PI-QUAL): A New Quality Control Scoring System for Multiparametric Magnetic Resonance Imaging of the Prostate from the PRECISION trial. Eur Urol Oncol 3:615\u2013619","journal-title":"Eur Urol Oncol"},{"key":"5780_CR3","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1148\/radiol.2020190646","volume":"296","author":"AC Westphalen","year":"2020","unstructured":"Westphalen AC, McCulloch CE, Anaokar JM et al (2020) Variability of the Positive Predictive Value of PI-RADS for Prostate MRI across 26 Centers: Experience of the Society of Abdominal Radiology Prostate Cancer Disease-focused Panel. Radiology 296:76\u201384","journal-title":"Radiology"},{"key":"5780_CR4","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1016\/S1470-2045(24)00220-1","volume":"25","author":"A Saha","year":"2024","unstructured":"Saha A, Bosma JS, Twilt JJ et al (2024) Artificial intelligence and radiologists in prostate cancer detection on MRI (PI-CAI): an international, paired, non-inferiority, confirmatory study. Lancet Oncol 25:879\u2013887","journal-title":"Lancet Oncol"},{"key":"5780_CR5","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/S0140-6736(16)32401-1","volume":"389","author":"HU Ahmed","year":"2017","unstructured":"Ahmed HU, El-Shater Bosaily A, Brown LC et al (2017) Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study. Lancet 389:815\u2013822","journal-title":"Lancet"},{"key":"5780_CR6","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1056\/NEJMoa1801993","volume":"378","author":"V Kasivisvanathan","year":"2018","unstructured":"Kasivisvanathan V, Rannikko AS, Borghi M et al (2018) MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis. N Engl J Med 378:1767\u20131777","journal-title":"N Engl J Med"},{"key":"5780_CR7","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/S1470-2045(18)30569-2","volume":"20","author":"O Rouviere","year":"2019","unstructured":"Rouviere O, Puech P, Renard-Penna R et al (2019) Use of prostate systematic and targeted biopsy on the basis of multiparametric MRI in biopsy-naive patients (MRI-FIRST): a prospective, multicentre, paired diagnostic study. Lancet Oncol 20:100\u2013109","journal-title":"Lancet Oncol"},{"key":"5780_CR8","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.1056\/NEJMoa2209454","volume":"387","author":"J Hugosson","year":"2022","unstructured":"Hugosson J, Mansson M, Wallstrom J et al (2022) Prostate Cancer Screening with PSA and MRI Followed by Targeted Biopsy Only. N Engl J Med 387:2126\u20132137","journal-title":"N Engl J Med"},{"key":"5780_CR9","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1097\/JU.0000000000004104","volume":"212","author":"P Lewicki","year":"2024","unstructured":"Lewicki P, Morgan T (2024) MRI-Visible and -Invisible Prostate Cancer. J Urol 212:499\u2013500","journal-title":"J Urol"},{"key":"5780_CR10","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1002\/ijc.34743","volume":"154","author":"TK Lehto","year":"2023","unstructured":"Lehto TK, Pylvalainen J, Sandeman K et al (2023) Histomic and transcriptomic features of MRI-visible and invisible clinically significant prostate cancers are associated with prognosis. Int J Cancer 154:926\u2013939","journal-title":"Int J Cancer"},{"key":"5780_CR11","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.1016\/j.euo.2024.09.017","volume":"8","author":"T Fazekas","year":"2024","unstructured":"Fazekas T, Pallauf M, Kufel J et al (2024) Molecular Correlates of Prostate Cancer Visibility on Multiparametric Magnetic Resonance Imaging: A Systematic Review. Eur Urol Oncol 8:1352\u20131364","journal-title":"Eur Urol Oncol"},{"key":"5780_CR12","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.eururo.2020.03.048","volume":"78","author":"NJ Sathianathen","year":"2020","unstructured":"Sathianathen NJ, Omer A, Harriss E et al (2020) Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in the Detection of Clinically Significant Prostate Cancer in the Prostate Imaging Reporting and Data System Era: A Systematic Review and Meta-analysis. Eur Urol 78:402\u2013414","journal-title":"Eur Urol"},{"key":"5780_CR13","doi-asserted-by":"crossref","unstructured":"Turkbey B, Rosenkrantz AB, Haider MA et al (2019) Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2. Eur Urol 76:340\u2013351","DOI":"10.1016\/j.eururo.2019.02.033"},{"key":"5780_CR14","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.eururo.2024.03.027","volume":"86","author":"P Cornford","year":"2024","unstructured":"Cornford P, van den Bergh RCN, Briers E et al (2024) EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer-2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent. Eur Urol 86:148\u2013163","journal-title":"Eur Urol"},{"key":"5780_CR15","doi-asserted-by":"publisher","first-page":"e231383","DOI":"10.1148\/radiol.231383","volume":"311","author":"N Schieda","year":"2024","unstructured":"Schieda N, Nisha Y, Hadziomerovic AR et al (2024) Comparison of Positive Predictive Values of Biparametric MRI and Multiparametric MRI-directed Transrectal US-guided Targeted Prostate Biopsy. Radiology 311:e231383","journal-title":"Radiology"},{"key":"5780_CR16","first-page":"CD012663","volume":"4","author":"FH Drost","year":"2019","unstructured":"Drost FH, Osses DF, Nieboer D et al (2019) Prostate MRI, with or without MRI-targeted biopsy, and systematic biopsy for detecting prostate cancer. Cochrane Database Syst Rev 4:CD012663","journal-title":"Cochrane Database Syst Rev"},{"key":"5780_CR17","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-025-12269-7","author":"E Messina","year":"2026","unstructured":"Messina E, Borrelli A, Mezzapesa F et al (2026) Artificial intelligence-assisted reading of non-contrast prostate MRI: application and concordance with expert interpretation in a screening population within the PROSA trial. Eur Radiol. https:\/\/doi.org\/10.1007\/s00330-025-12269-7","journal-title":"Eur Radiol"},{"key":"5780_CR18","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.eururo.2023.12.015","volume":"86","author":"JC Hu","year":"2024","unstructured":"Hu JC, Assel M, Allaf ME et al (2024) Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted and Systematic Prostate Biopsy to Prevent Infectious Complications: The PREVENT Randomized Trial. Eur Urol 86:61\u201368","journal-title":"Eur Urol"},{"key":"5780_CR19","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/j.euo.2024.01.019","volume":"7","author":"G Ploussard","year":"2024","unstructured":"Ploussard G, Barret E, Fiard G et al (2024) Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted Biopsies for Prostate Cancer Diagnosis: Final Results of the Randomized PERFECT trial (CCAFU-PR1). Eur Urol Oncol 7:1080\u20131087","journal-title":"Eur Urol Oncol"},{"key":"5780_CR20","doi-asserted-by":"publisher","first-page":"797","DOI":"10.3390\/biomedicines14040797","volume":"14","author":"M Gurcan","year":"2026","unstructured":"Gurcan M, Ates Y, Erden ME et al (2026) Diagnostic Performance of Perineal MRI\u2013US Fusion Prostate Biopsy: A Single-Center Prospective Cohort Analysis. Biomedicines 14:797","journal-title":"Biomedicines"},{"key":"5780_CR21","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/s41391-023-00729-4","volume":"27","author":"Q Wu","year":"2023","unstructured":"Wu Q, Tu X, Zhang C et al (2023) Transperineal magnetic resonance imaging targeted biopsy versus transrectal route in the detection of prostate cancer: a systematic review and meta-analysis. Prostate Cancer Prostatic Dis 27:212\u2013221","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"5780_CR22","doi-asserted-by":"publisher","unstructured":"Marra G, Bazzurro F, Dematteis A et al (2026) Transperineal Versus Transrectal Biopsy for Prostate Cancer Diagnosis: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Eur Urol Oncol. https:\/\/doi.org\/10.1016\/j.euo.2026.01.009","DOI":"10.1016\/j.euo.2026.01.009"},{"key":"5780_CR23","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.eururo.2022.01.008","volume":"82","author":"WG Brisbane","year":"2022","unstructured":"Brisbane WG, Priester AM, Ballon J et al (2022) Targeted Prostate Biopsy: Umbra, Penumbra, and Value of Perilesional Sampling. Eur Urol 82:303\u2013310","journal-title":"Eur Urol"},{"key":"5780_CR24","doi-asserted-by":"publisher","first-page":"103164","DOI":"10.1016\/j.eclinm.2025.103164","volume":"82","author":"Q Wu","year":"2025","unstructured":"Wu Q, Wang J, Tu X et al (2025) Optimizing the strategies to perform prostate biopsy in MRI-positive patients: a systematic review and network meta-analysis. EClinicalMedicine 82:103164","journal-title":"EClinicalMedicine"},{"key":"5780_CR25","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1097\/JU.0000000000004863","volume":"215","author":"R Deng","year":"2025","unstructured":"Deng R, Li D, Wu J et al (2025) Comprehensive Evaluation of Targeted and Perilesional Biopsy in Biopsy-Naive Patients With Prostate Positive Magnetic Resonance Imaging: PERI-PRO Noninferiority Randomized Controlled Trial. J Urol 215:408\u2013420","journal-title":"J Urol"},{"key":"5780_CR26","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.euo.2023.08.002","volume":"7","author":"S Wang","year":"2024","unstructured":"Wang S, Kozarek J, Russell R et al (2024) Diagnostic Performance of Prostate-specific Antigen Density for Detecting Clinically Significant Prostate Cancer in the Era of Magnetic Resonance Imaging: A Systematic Review and Meta-analysis. Eur Urol Oncol 7:189\u2013203","journal-title":"Eur Urol Oncol"},{"key":"5780_CR27","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.euo.2020.08.008","volume":"5","author":"TFW Soeterik","year":"2022","unstructured":"Soeterik TFW, van Melick HHE, Dijksman LM et al (2022) Development and External Validation of a Novel Nomogram to Predict Side-specific Extraprostatic Extension in Patients with Prostate Cancer Undergoing Radical Prostatectomy. Eur Urol Oncol 5:328\u2013337","journal-title":"Eur Urol Oncol"},{"key":"5780_CR28","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.eururo.2021.07.027","volume":"81","author":"E Mazzone","year":"2022","unstructured":"Mazzone E, Gandaglia G, Ploussard G et al (2022) Risk Stratification of Patients Candidate to Radical Prostatectomy Based on Clinical and Multiparametric Magnetic Resonance Imaging Parameters: Development and External Validation of Novel Risk Groups. Eur Urol 81:193\u2013203","journal-title":"Eur Urol"},{"key":"5780_CR29","doi-asserted-by":"publisher","first-page":"1425134","DOI":"10.3389\/fmed.2024.1425134","volume":"11","author":"Y Wang","year":"2024","unstructured":"Wang Y, Jing R, Wang H, Zhao Q (2024) (68)Ga-PSMA-11 PET and mpMRI in the diagnosis of initial lymph node staging of prostate cancer: a head-to-head comparative meta-analysis. Front Med (Lausanne) 11:1425134","journal-title":"Front Med (Lausanne)"},{"key":"5780_CR30","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.eururo.2024.03.014","volume":"86","author":"C Englman","year":"2024","unstructured":"Englman C, Maffei D, Allen C et al (2024) PRECISE Version 2: Updated Recommendations for Reporting Prostate Magnetic Resonance Imaging in Patients on Active Surveillance for Prostate Cancer. Eur Urol 86:240\u2013255","journal-title":"Eur Urol"},{"key":"5780_CR31","doi-asserted-by":"publisher","first-page":"e70079","DOI":"10.1002\/bco2.70079","volume":"6","author":"PCC Viana","year":"2025","unstructured":"Viana PCC, Queiroz MA, Ferreira FO et al (2025) Multiparametric MRI combined with PSA density as a noninvasive rule-out strategy in active surveillance for prostate cancer. BJUI Compass 6:e70079","journal-title":"BJUI Compass"}],"container-title":["Abdominal Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-026-05780-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00261-026-05780-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-026-05780-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T13:38:47Z","timestamp":1789047527000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00261-026-05780-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":31,"alternative-id":["5780"],"URL":"https:\/\/doi.org\/10.1007\/s00261-026-05780-y","relation":{},"ISSN":["2366-0058"],"issn-type":[{"value":"2366-0058","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,10]]},"assertion":[{"value":"7 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}